Information

	Learning Objectives
	Update in HIV		Appropriately apply the latest findings and treatment paradigms in HIV to the clinical care of HIV infected KP members.
	Sexually Transmitted Diseases in 2017		Appropriately apply the latest findings and treatment paradigms in sexually transmitted diseases to the clinical care of KP members.
	Key Note Address - Getting to Zero		Use strategies to successfully engage in promoting diagnosis, linkage and retention in care, and treatment for patients and Americans infected with HIV and/or hepatitis B/C.
	HIV: Renal and Bone Diseases		Utilize the latest diagnostic and management approaches to HIV-related kidney and bone disease.
	Hepatitis Care Pathway - How to Set-up a Comprehensive HCV Diagnostic and Access to Care Program		Describe the hepatitis care pathway in KPMAS and generate ideas about translating this pathway to other KP regions.
	How Do we Get to Universal HIV testing at KP?		Develop a strategy to move KP closer to the goal of universal testing, describe roadblocks to that goal and develop a strategy to overcome some of these obstacles.
	Drug-Drug Interactions - HIV and HCV		Describe the latest data in drug-drug interactions of HIV and HCV drugs with other commonly prescribed medications. Use strategies to prevent drug-drug interactions.
	Update in HCV and HBV		Appropriately apply the latest findings and treatment paradigms in HBV and HCV to the clinical care of HCV and HBV infected KP members.
	HIV and Hepatitis Clinical Controversies - A Case Based Format		Identify gaps in their own clinical practices and implement changes to clinical practice to improve quality performance. Describe and implement the latest HIV and hepatitis treatment paradigms in care.
	Sexual Health - Care of Men who have Sex with Men		Describe the unique health issues of an MSM patient and provide appropriate care to this patient population.
	Hepatitis: Liver transplant Update		Describe the care requirements for patients who are being referred for transplant and what additional care needs exist for these patients pre/post-transplant.
	HIV/STD: Screening for and Management of Anal Dysplasia: What is the Evidence and the Strategies?		Describe the evidence based diagnosis and care for anal dysplasia.
	Key Learnings: Promising Practices around HIV Care with Community-Based Organizations		Screen for and assess the factors that put socially vulnerable HIV patients at-risk for falling out of care.
	HIV and Youth		Improve HIV screening for youth at risk for HIV and improve access to PrEP. Improve linkage to care, ARV adherence and retention in care for Youth living with HIV.
	Non-viral Hepatitis		Describe the prevalence, risk factors, screening, treatments and investigational treatments for nonviral hepatitis.
	Cardiovascular Disease and HIV		Describe and implement the most recent evidence-based approaches to prevention and treatment of cardiovascular complications of HIV disease.
	Hepatitis - HCV Treatment Failure Today and Other Thorny Issues (Like HCV Genotype 3)		Describe and implement treatment and diagnostic strategies for HCV-infected patients who fail initial anti-HCV treatment or have genotypes that are not responsive to generally recommended antiviral agents.
	Using Data to Improve Quality of Care within HIV, PrEP, HCV and HBV - A Panel Discussion		Develop a patient registry for a population of patients and utilize the registry to improve care.
	Update in Substance Abuse 2017		Include drug abuse screening and treatment into clinical practice.
	PrEP 2017		Develop an efficient, cost effective, patient-centered PrEP program and develop tools to monitor patients and outcomes.


	Accreditation Designation Statement The Kaiser Permanente National CME Program is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Credit Statement The Kaiser Permanente National CME Program designates this live activity for a maximum of 10.75 AMA PRA Category 1 Credits.™ Physicians should claim only the credit commensurate with the extent of their participation in the activity. This credit may also be applied to the CMA Certification in Continuing Medical Education. Day 1: 6.75 Day 2: 4.0 Total: 10.75 Nurses and Physician Assistants – Attendees may report up to 10.75 hours toward continuing education requirements for license renewal. ‘CME’ can be written in lieu of the provider number on all licensure renewal applications. Target Audience: Primary Care Physicians, Pharmacists, Physician Assistants, Nurse Practitioners, Nurses, Psychologists, Research Scientists and Research Staff. Specialist in HIV, Infectious Disease, Hepatitis, Cardiology, Family Medicine, Internal Medicine, OB/GYN, Oncology, and Gastroenterology PERSONS WITH DISABILITIES In compliance with the Americans with Disabilities Act, all reasonable efforts will be made to accommodate persons with disabilities at the meeting. If you have any special dietary or accommodation needs, please notify the meeting planner listed, prior to the symposium in the Department of Physician Education at (626) 405-4630 or tie-line 8-335-4630. This advance notice will help us serve you better. FOR FURTHER INFORMATION Katherine Martinez Kleine Senior Meeting Planner SCPMG Meetings and Events katherine.m.kleine@kp.org